BC
CME icon

Bowman & Company’s CME Group CME Stock Holding History

Bowman & Company’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.51M Buy
9,195
+16
+0.2% +$4.35K 1.06% 25
2025
Q3 		$2.48M Sell
9,179
-62
-0.7% -$16.9K 1.05% 24
2025
Q2 		$2.55M Buy
9,241
+15
+0.2% +$4.08K 1.14% 22
2025
Q1 		$2.45M Buy
9,226
+614
+7% +$151K 1.2% 21
2024
Q4 		$2M Buy
8,612
+188
+2% +$43.2K 1.03% 25
2024
Q3 		$1.86M Buy
8,424
+768
+10% +$159K 0.97% 26
2024
Q2 		$1.51M Buy
7,656
+621
+9% +$128K 0.87% 29
2024
Q1 		$1.52M Sell
7,035
-62
-0.9% -$13K 0.91% 25
2023
Q4 		$1.5M Buy
7,097
+408
+6% +$87.1K 1.04% 22
2023
Q3 		$1.34M Buy
6,689
+365
+6% +$72.6K 1.07% 24
2023
Q2 		$1.17M Buy
6,324
+256
+4% +$47.3K 0.89% 26
2023
Q1 		$1.16M Buy
6,068
+1,155
+24% +$209K 0.85% 27
2022
Q4 		$826K Sell
4,913
-59
-1% -$10.3K 0.64% 34
2022
Q3 		$881K Buy
4,972
+216
+5% +$42.7K 0.8% 26
2022
Q2 		$973K Buy
4,756
+773
+19% +$164K 0.85% 26
2022
Q1 		$947K Buy
3,983
+614
+18% +$144K 0.73% 23
2021
Q4 		$773K Buy
+3,369
New +$741K 0.6% 27

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bowman & Company's CME Position: Q4 2025 in Review

Bowman & Company increased its CME Group (CME) stake by 0.17% in Q4 2025, buying an estimated $4.35K and bringing the position to 9,195 shares worth $2.51M. The position accounts for 1.06% of the portfolio, ranked #25.

Bowman & Company first reported a position in CME in Q4 2021 and has held it in 17 quarters since. The position peaked at $2.55M in Q2 2025. 1,732 funds tracked by Wall St. Rank hold CME as of Q4 2025.

  • Bowman & Company held 9,195 shares of CME Group worth $2.51M as of Q4 2025.
  • Bowman & Company bought 16 CME Group shares in Q4 2025, an estimated $4.35K.
  • CME Group made up 1.06% of Bowman & Company's portfolio in Q4 2025, its #25 holding.
  • Bowman & Company first reported a position in CME Group in Q4 2021 and has held it in 17 quarters since.
  • Bowman & Company's CME Group position peaked at $2.55M in Q2 2025.
  • 1,732 funds tracked by Wall St. Rank held CME Group as of Q4 2025.

Based on Bowman & Company's 13F filing for Q4 2025, filed 23 Jan 2026.